In addition, in order to promote the increase of glycolysis and support tumor cell viability, K-RAS increases the hexosamine biosynthesis pathway (HBP) and the non-oxidative arm of the pentose phosphate pathway (PPP); the latter generates ribose-5-phosphate for de novo nucleotide biosynthesis [18,65]. The gene discussed is KRAS; the disease is neoplasm.